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Abstract 
Objective: To systematically review published studies of interventions to reduce 
people’s intake of dietary trans-fatty acids (TFAs). 
Methods: We searched online databases (CINAHL, the CRD Wider Public 
Health database, Cochrane Database of Systematic Reviews, Ovid®, MEDLINE®, 
Science Citation Index and Scopus) for studies evaluating TFA interventions 
between 1986 and 2017. Absolute decrease in TFA consumption (g/day) was the 
main outcome measure. We excluded studies reporting only on the TFA content in 
food products without a link to intake. We included trials, observational studies, 
meta-analyses and modelling studies. We conducted a narrative synthesis to 
interpret the data, grouping studies on a continuum ranging from interventions 
targeting individuals to population-wide, structural changes. 
Results: After screening 1084 candidate papers, we included 23 papers: 12 
empirical and 11 modelling studies. Multiple interventions in Denmark achieved a 
reduction in TFA consumption from 4.5 g/day in 1976 to 1.5 g/day in 1995 and then 
virtual elimination after legislation banning TFA in manufactured food in 2004. 
Elsewhere, regulations mandating reformulation of food reduced TFA content by 
about 2.4 g/day. Worksite interventions achieved reductions averaging 1.2 g/day. 
Food labelling and individual dietary counselling both showed reductions of around 
0.8 g/day. 
Conclusion: Multicomponent interventions including legislation to eliminate 
TFAs from food products were the most effective strategy. Reformulation of food 
products and other multicomponent interventions also achieved useful reductions in 
TFA intake. By contrast, interventions targeted at individuals consistently achieved 
smaller reductions. Future prevention strategies should consider this effectiveness 
hierarchy to achieve the largest reductions in TFA consumption. 
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Introduction 
Over two-thirds of the global burden of disability and death is attributable to 
noncommunicable diseases. Diseases such as cardiovascular diseases, common cancers, 
dementia, diabetes and respiratory disorders kill over 35 million people annually.1 The World 
Health Organization (WHO) priority areas for reducing noncommunicable diseases include 
tobacco, alcohol, physical inactivity and poor diet. Poor diet generates a larger burden of 
disease than the other three risk factors combined. It accounts for an estimated 11.3 million 
deaths annually, compared with 2.1 million for low physical activity, 6.1 million for tobacco 
smoke and 3.1 million for alcohol and drug use.1 The problem predominantly reflects an 
unhealthy global food environment dominated by processed foods high in sugar, salt, 
saturated fats and, crucially, industrial trans-fatty acids (TFAs).1 
TFAs are found naturally in small amounts in some meat and dairy products produced 
by bacterial action in the stomach of ruminant animals.2 However, the majority of TFAs are 
industrial, being manufactured by partial hydrogenation of edible vegetable oils, such as palm 
oil, cottonseed oil, soybean oil or canola oil.3 Industrial TFAs are then added to processed or 
packaged food, mainly to prolong shelf life and enhance taste and texture at a low cost.4 
Since the 1990s, research evidence has accumulated demonstrating that TFA consumption 
substantially increases people’s risk of coronary heart disease.2,5 It does this mainly by 
elevating harmful low-density lipoprotein cholesterol levels and decreasing protective high-
density lipoprotein cholesterol.2 TFAs may also increase the risk of Alzheimer’s disease and 
certain cancers,2 and worsen insulin sensitivity thereby increasing the risk of type 2 diabetes.5 
A reduction in people’s intake of industrial TFA is thus a WHO policy priority.2 
However, TFA intake in most countries still exceeds the WHO target of 2 g/day, mainly 
reflecting consumption of industrial TFAs in processed food.6 Furthermore, even as overall 
TFA consumption falls, intake is likely to remain higher in poorer populations, who are more 
likely to eat processed food products.7 Different strategies and policy options, targeting 
different groups, have been proposed to meet these targets. These can be described as 
upstream or downstream interventions. Downstream interventions generally target 
individuals and involve behavioural approaches.8 Intermediate interventions target subgroups 
in worksites, schools or communities. Both downstream and intermediate interventions are 
dependent on the individual to respond. By contrast, upstream interventions take place at the 
population level and typically involve regulatory approaches, taxes or subsidies. By creating 
a healthier environment, they avoid any dependence on an individual response.8 In alcohol 
and tobacco control policies, for instance, an effectiveness hierarchy of preventive 
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interventions has been observed, whereby population-wide policy interventions appear to be 
consistently more powerful than interventions targeting individuals.9,10 
Policy interventions to remove industrial TFAs from foods have therefore been 
suggested as the most effective public health approach for reducing TFA intake and 
decreasing the burden of noncommunicable diseases.11 Some countries have demonstrated 
that this is feasible. In Denmark, for example, multicomponent interventions progressively 
reduced the population’s TFA intake and a subsequent legislative ban virtually eliminated 
TFAs in margarines and vegetable shortenings.12 However, that success required substantial 
political will sustained over a decade. Most other countries only have achieved voluntary 
TFAs limits, reflecting concerns about political feasibility and generally lower levels of 
public pressure for change.13 
The evidence supporting the most effective policies for reducing TFA intake remains 
unclear. To inform future prevention strategies we conducted a systematic review of the 
evidence on the effectiveness of interventions to reduce people’s TFA intake. We also 
hypothesized that an effectiveness hierarchy might exist. 
Methods 
Data sources and searches 
We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
guidelines.14 We carried out a systematic search of online databases (CINAHL, the Centre for 
Reviews and Dissemination Wider Public Health database, Cochrane Database of Systematic 
Reviews, Ovid®, MEDLINE®, Science Citation Index and Scopus) for studies of 
interventions to reduce people’s TFA intake, published between 1985 and 24 August 2017. A 
combination of relevant keywords, identified from exemplar papers (including a systematic 
review of policies for reducing dietary TFA),15 was used to construct the search strategy 
(Box 1). All identified papers were imported into a web-based data management software 
(Zotero, version 4.0.29, Roy Rosenzweig Center for History and New Media, Fairfax, United 
States of America). 
One author conducted the searches and removed the duplicates. Two authors then 
independently screened titles and abstracts for eligibility; if they deemed papers eligible, the 
full text was retrieved and again screened independently. We also scanned reference lists of 
included studies for potential relevant papers. Any differences in screening outcomes were 
resolved either by consensus, or by involving the senior author. 
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Study selection 
We included a wide range of study designs including trials, observational studies, meta-
analyses and modelling studies. Modelling studies added value by allowing the evaluation of 
certain interventions using different scenarios where empirical data are impractical or lacking 
(e.g. food labelling). However, we analysed them separately form the empirical studies. To be 
eligible, studies had to include the effectiveness of specific interventions on dietary TFA 
intake and have quantitative outcomes. Only studies published in English language were 
included. We assessed retrieved studies by using the population, intervention, comparison 
and outcomes study design approach (Box 2).14 
The primary outcome was dietary TFA intake in a population, reported as g/day. For 
studies reporting TFA intake as a percentage of total energy intake (E%), we converted the 
data to g/day using the conventional formula below (1).16 
Trans	fat	intake	   = 2000	 × 	
		%
!"" /	9 (1) 
Papers only reporting on the reduction of TFA content in food products without a link 
to intake were excluded. 
Secondary outcomes included changes in clinical or physiological indicators related to 
noncommunicable diseases (e.g. coronary heart disease deaths) and behaviours associated 
with a healthy diet. 
Data extraction and quality assessment 
We used pre-designed and pre-piloted data extraction forms to extract data from all included 
studies. One author conducted the data extraction, which was independently checked by other 
authors for the empirical and modelling studies. 
We used the National Heart, Lung and Blood Institute quality assessment tools to 
assess the quality of empirical studies.17 Two authors independently assessed the 
methodological quality of each study as poor, fair or good. Modelling studies were 
independently assessed by two modelling experts using an adapted version of a published 
quality assessment tool.18 Quality was reported as poor, fair or good. Any disagreements were 
resolved by consensus or with another author. 
Data synthesis and analysis 
We conducted a narrative synthesis to interpret the data, grouping the studies according to 
intervention type. In accordance with the McLaren continuum of structural‒agentic 
interventions8 and the Nuffield ladder taxonomy,19 we defined downstream (agentic) 
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interventions as those where the principal mechanism of action is dependent on individuals 
altering their consumption behaviour. Conversely, we defined upstream (structural) 
interventions as those creating changes that target an entire population ‒ not a subset, 
however large ‒ thus effectively eliminating individual agency. We then categorized 
interventions according to their position in the McLaren continuum (Fig. 1).8 We separately 
analysed multicomponent interventions. An unweighted median regression model was fitted 
to the TFA intake data from eight empirical studies and four modelling studies. 
Results 
The literature search identified 1785 potentially relevant papers, and 22 additional papers 
were identified through screening reference lists. After removing 723 duplicates, we screened 
1084 publications by title and abstract, after which 70 full-text papers were assessed for 
eligibility. A total of 23 papers met the inclusion criteria (12 empirical studies20–31 and 11 
modelling studies;32–42 Fig. 2). The interventions and their effect sizes are presented in Fig. 3. 
Table 1 summarizes the empirical studies and Table 2 summarizes modelling studies 
included in this review (both tables available at: 
http://www.who.int/bulletin/volumes/95/##/##-######). 
Individual dietary counselling  
One study in 2007, rated as fair quality, targeted Aboriginal families in Canada. It 
investigated the effect of dietary counselling on dietary intake, including TFA, using a 24-
hour recall. The 29 intervention households significantly reduced their consumption of TFA 
(P = 0.02) from 0.6 to 0.5 g/day over 6 months, while the 28 control households increased 
consumption from 0.7 to 1.3 g/day.20 
Worksite dietary counselling 
One poor-quality study in 2010 in the USA implemented a dietary counselling programme at 
a worksite by educating participants on the use of a low-fat vegan diet. After 22 weeks, 3-day 
dietary records showed that the 45 control participants had increased their TFA intake from 
2.4 to 2.5 g/day over 22 weeks, whereas the 68 participants in the intervention group reduced 
their intake from 2.1 to 1.1 g/day (P ≤ 0.001).21 
Food labelling 
Modelling studies 
We found no empirical studies investigating the sole effect of labels showing the TFA 
content of food products, but we included five modelling studies (two of good quality,32,33 
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two fair34,35 and one of poor quality36). In the Netherlands a healthier choices logo for food 
packages was implemented in 2006. Replacing all packaged products with those that 
complied with a healthier choices logo was projected to lead to a 0.8 g/day reduction in TFA 
intake from 2.1 to 1.3 g/day.34 Another Dutch study in 2013, using a similar approach, 
projected a higher reduction of 1.2 g/day (from 2.2 to 1.0 g/day).35 A British study in 2015 
estimated that labelling is at best only half as effective as a total ban on TFAs in terms of 
health and socioeconomic benefits. Improved labelling might save approximately 3500 
deaths from coronary heart disease over the period 2015–2020 (1.3%, 3500 of the total 
273 000 deaths) and reduce socioeconomic inequalities by some 1500 deaths (from 20 400 to 
18 900).32 Another modelling study in 2016 investigated the cost‒effectiveness of mandatory 
labelling in products on sale in the European Union (EU) and projected that it may prevent 
0.98 million of the 1076 million disability-adjusted life years (DALYs) attributed to coronary 
artery disease. However, compared with taking no action, this option incurred greater costs 
than it saved, in terms of health-care costs, lost productivity and implementation costs.33 In a 
similar approach to the Dutch study, researchers in in Brazil investigated replacing products 
with ones that complied with a healthy choices logo.36 Estimated TFA intakes were 0.8 g/day 
(standard deviation, SD: 1.0) for typical menus, 0.1 g/day (SD: 0.2) for the choices menus 
and 0.2 g/day (SD: 0.3) for energy-adjusted choices menus, i.e. the same as choices menu but 
adjusted for energy of typical menu. 
Food reformulation 
Empirical studies 
Two empirical studies examined the effect of reformulating industrially produced foods. A 
good-quality study reported the results of a TFA monitoring programme after voluntary 
reformulation limits for TFA content were put in place in Canada in 2005 on vegetable oils 
and soft margarines and other pre-packaged foods (<  2% and <  5% of total fat, respectively). 
TFA intake, measured using 24-hour food recalls in the general population (33 030 people), 
fell from 4.9 g/day in 2004 to 3.4 g/day in 2008.22 
The other study, rated as fair quality, conducted two meta-analyses of North 
American and European data. Both analyses investigated the effect of TFA consumption on 
coronary heart disease risk factors (one included 13 randomized controlled trials and the 
other covered four prospective studies). The researchers calculated the effect of reformulating 
the TFA content of partially hydrogenated vegetable oils with other fats. They found higher 
risk reductions when reformulating oils with higher TFA content. The randomized controlled 
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trials reported an approximately 19% risk reduction, whereas the prospective studies found a 
39% reduction in coronary heart disease risk.23 
Modelling studies 
One study of poor quality in 2011 modelled the effect of reformulation of foods to reduce 
TFA in the Netherlands. TFA intake in the population of 750 participants aged 19–30 years 
was projected to fall from 2.3 to 1.9 g/day after reformulating specific food groups (e.g. 
bread, pastry, cakes and biscuits; meat snacks and salads; fat and margarines).37 Another 
study of fair quality modelled the effect of food reformulation on health outcomes in 
Denmark in 2016. The researchers estimated reductions in cardiovascular disease deaths of 
14.2 (from 441.5 to 427.3) per 100 000 population over the years 2004‒2006 and coronary 
heart disease deaths 26.5 per 100 000 population.38 Finally, one good-quality modelling study 
of EU-level policy options investigated the cost‒effectiveness of voluntary reformulation 
compared with no intervention. The study estimated 2.19 of 1075 million DALYs could be 
averted from coronary artery disease over the course of a person’s lifetime (85 years). A 
projected 23 billion euros (€) could be saved due to reductions in direct health-care costs and 




Analysing TFA g/purchase not TFA g/day, one good-quality study investigated the effect of 
regulations on TFA content of food sold in New York city. Instituted in 2007, the policy 
allowed takeaway food restaurants to sell only products with a ≤ 0.5 g TFA content per 
serving. The estimated mean TFA intake per purchase, based on purchase receipts matched to 
products, decreased from 2.9 g in 2007 (6969 purchases) to 0.5 g in 2009 (7885 purchases).24 
Another study of good quality analysed the impact of a upper limit of 0.5 g/serving 
(commonly referred to as a TFA ban) on TFAs in all food-service establishments in the USA 
in 2016 and found a 4.5% reduction in cardiovascular disease mortality, from 13 per 100 000 
persons between 2010 and 2013.25 
Finally, a study of good quality investigated the effect of TFA restrictions in 
restaurants in certain New York state counties implemented in 2007, comparing hospital 
admissions for cardiovascular events in counties with and without restrictions. Three or more 
years after the restrictions were implemented there were significantly fewer cardiovascular 
events in the intervention population of 8.4 million adults compared with the reference 
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population of 3.3 million, after adjusting for temporal trends. These changes applied when 
analysing myocardial infarction and stroke events combined (change of −6.2%; 95% 
confidence interval, CI: −9.2% to −3.2%) and myocardial infarction alone (−7.8%; 95% CI: 
−12.7% to −2.8%).26 
Modelling studies 
Five modelling studies, all of good quality, modelled the effect on health outcomes of 
legislation affecting TFA consumption.32,33,39–41 One British study projected that a ban on 
TFAs in sit-down and takeaway restaurants for the period 2015‒2020 would save 
approximately 1800 (0.7%) coronary heart disease deaths annually in the population. A total 
ban of TFAs in all products might achieve some 7200 (2.6%) fewer deaths from coronary 
heart disease and reduce socioeconomic inequalities in coronary heart disease mortality by 
approximately 3000 deaths.32 Two other British studies found that legislation to achieve a 
0.5% reduction in the total energy derived from dietary TFA could prevent 270039 or 3700 
cardiovascular disease deaths annually.40 Another British study modelled the effect of 
eliminating TFA from industrially produced food and estimated this could prevent around 
1700 coronary heart disease deaths and gain some 15 000 life years annually over a decade. 
Eliminating both natural- and industrial-derived TFAs may prevent some 3300 coronary heart 
disease deaths annually and gain approximately 30 000 life years.41 Finally, a study in 2016 
modelled the cost‒effectiveness of different EU policy options to reduce the TFA intake of 
the population. Placing legal limits on the TFA content in industrial foods was projected to 
avoid 3.73 DALYs and save € 51 billion from health-care costs and lost productivity in EU 
Member States.33 
Multicomponent interventions 
Empirical studies  
Four fair-quality empirical studies investigated the combined effect of more than one policy 
on TFA consumption.27–30 One cross-sectional study evaluated the effect of both a public 
health education programme and voluntary reformulation of industrially produced TFAs in 
soybean oil in Costa Rica. Using 3-day food records the study found a 1.7 g/day reduction in 
TFA intake among adolescents from 4.5 g/day (276 people) in 1996 to 2.8 g/day (133 people) 
in 2006.27 
Two other studies included both labelling and voluntary reformulation limits in 
Canada. Estimating TFA intake from breastmilk samples, they reported reductions in TFA 
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intake from 2.0 in 2009 to 0.7 g/day in 2011 (639 people)29 and from 4.0 to 2.2 g/day (87 
people).28 
An American cross-sectional population-based study analysed blood samples before 
and after introduction of food labelling and voluntary limits on TFA in restaurants. A 58% 
reduction in TFA levels was found, from 93.1 µmol/L (229 samples) in 2000 to 39.0 µmol/L 
(292 samples) in 2009, suggesting a substantial reduction in dietary intake of TFAs over the 
period.30 
From 1993 onwards, Denmark progressively implemented multiple interventions to 
reduce dietary TFA intake, including food labelling and voluntary agreements with 
industry.38 One study found that TFA intake dropped from 4.5 g/day to 1.5 g/day from 1976 
to 1995. Intake from margarines and shortenings virtually reduced to zero after legislation to 
ban industrially produced TFA in 2004.31 
Modelling studies 
One modelling study of fair quality used different scenarios to model the effect of food 
labelling and reformulation of food products on health outcomes in Argentina. Based on 
changes in lipid profile, the combined intervention was projected to avert 301 deaths, 1066 
acute coronary heart disease events, 5237 DALYs and 17 million United States dollars in 
health-care costs annually in the adult population.42 
Discussion 
Our systematic review suggests that multicomponent interventions achieve the biggest 
reductions in TFA consumption across an entire population, as demonstrated in Denmark, 
Canada and Costa Rica. Systematic reformulation of products containing TFAs can also help, 
as observed in Canada and the USA. Interventions targeting individuals typically achieved 
smaller reductions in TFA consumption. 
Several studies, in separate countries, investigated multicomponent interventions; all 
of them included food reformulation, labelling and voluntary limits on TFA content of 
industrial food. In Denmark, a progressive series of interventions finally led to a legislative 
ban on TFA. This package achieved the largest observed reduction in TFA intake in the 
population over the period from 1976 to 2005 (4.5 g/day).12,31 The USA is now emulating this 
successful strategy.43 Substantial but smaller benefits were achieved by multi-intervention 
strategies lacking a legislative component in Costa Rica27 and Canada.28,29 Multicomponent 
strategies including upstream policies, such as price regulations or legislation, consistently 
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achieved greater reductions in TFA intake than single interventions, particularly when these 
were downstream approaches focused on individuals. 
Legislation to regulate TFA content in food achieved a 2.4 g/day reduction in intake 
of TFA in the city of New York.24 This success has now been extended nationwide by the 
United States Food and Drug Administration ruling in June 2015 stating that partially 
hydrogenated oils are no longer generally recognized as safe for use in food.44 Following the 
Danish exemplar, several other European countries have subsequently introduced legislation, 
setting an upper limit for TFAs of 2 g per 100 g in fat or oil.13 However, other countries still 
rely on voluntary reformulation, which is less effective.13,15 Legislation is routinely opposed 
by the food industry, fearful of decreased profits or the additional costs of reformulating 
products.12,13,15 However, the evidence is that such legislation has generally had minimal 
financial impact on the food industry.12,31,45 
Several evaluation studies have reported reductions in TFA content of margarines and 
industrially produced foods, particularly using mandatory reformulation.24,46 An early 
concern that manufacturers would substitute saturated fats such as palm oil for TFA has been 
dismissed. Both Canadian and American studies of reformulation have reported reductions in 
both TFA and saturated fats, and increases in unsaturated fat,47 the preferred replacements for 
TFA.13 
Food labelling has the potential to help consumers make more informed decisions48 
and can also put pressure on the food industry to reformulate products.49 We found no 
empirical studies of the effects of food labelling alone. However, several modelling studies 
estimated reductions in TFA consumption ranging from 0.3 g/day to 1.2 g/day.32,34,35 In 
contrast, most studies involving food labelling have examined the public’s understanding of 
labels, use of labels, food purchase and purchase-related behaviour rather than quantifying 
TFA intake.50 The diverse labelling systems and claims currently generated by the industry 
may confuse many consumers, highlighting a need for package labels that are easier to 
understand.48 
Dietary counselling interventions in different settings, such as communities, 
worksites, schools and homes, were sparse. One study in the home20 and another in 
worksites21 both suggested that dietary counselling at an individual level could achieve TFA 
reductions of 0.8 g/day20 and 1.2 g/day.21 In practice, individuals may struggle to adhere and 
comply with dietary advice due to competing priorities or financial constraints.51 
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We found no studies of mass media campaigns focusing on TFA. Media campaigns 
can achieve modest beneficial behaviour changes in nutrition, physical activity and tobacco 
and alcohol use ‒ in motivated individuals. However, the overall population benefits tend to 
be more modest.52 
Taxation has been shown to be a potentially powerful tool for reducing consumption 
of tobacco, alcohol or sugar sweetened beverages. However, we found no studies of taxation 
focusing specifically on TFAs.13 
Our systematic review has several strengths. We did the screening, extraction and 
analysis in duplicate, and all the included studies were subjected to a rigorous quality 
appraisal. Furthermore, modelling studies were included but considered separately, in 
recognition of their additional uncertainties when compared with empirical evidence. Our 
review also had limitations. We were unable to conduct a meta-analysis due to the profound 
heterogeneity of the studies and because several studies included multiple interventions. We 
only included studies in English. The primary outcome of this study was dietary intake and 
we excluded studies considering other components of dietary behaviour or changes in product 
content after reformulation. Generalization of the results should be cautious because countries 
will vary in their baseline TFA intake. Furthermore, we did not contact authors for missing 
data. Publication bias also remains possible, potentially overestimating the true effect of some 
interventions. Finally, some intervention benefits may have been overestimated due to 
underlying secular trends among the public towards lower TFA consumption. 
In conclusion, our results suggest an effectiveness hierarchy similar to those 
previously demonstrated in salt, tobacco and alcohol control interventions.9,10,53 
Multicomponent interventions including a legislative ban on products appear the most 
effective strategy to reduce TFA intake. By contrast, more downstream interventions 
targeting individuals in domestic or work settings appear consistently less effective. Future 
prevention strategies might consider this effectiveness hierarchy to achieve the largest 
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Box 1. Search strategy used in the systematic review of dietary trans-fatty acid 
reduction policies 
The following keywords were used in a search of CINAHL, the Centre for Reviews 
and Dissemination Wider Public Health database, Cochrane Database of Systematic 
Reviews, Ovid®, MEDLINE®, Science Citation Index and Scopus: 
((“Trans-fats” OR “trans-fats” OR “Trans-fat” OR “Dietary trans-fat” OR “Industrial 
trans-fat”) AND (“Reformulation” OR “Regulation” OR “Self-regulation” OR 
“Labelling” OR “Limits” OR “Ban” OR “Elimination” OR “Legislation” OR 
“Agreements” OR “Campaigns” OR “Tax” OR “Health promotion” OR “Nutrition 
education” OR “Marketing control”) 
For Scopus, additional terms were used to narrow down the search: 
((“Intake” OR “Consumption” OR “Composition” OR “Content” OR “Effect” OR 
“Effectiveness” OR “Cons-effectiveness”) AND (“Public policy” OR “Nutrition policy” 
OR “Health policy” OR “Policies” OR “Interventions” OR “Strategies” OR “Initiatives” 
OR “Policy options” OR “Actions”)) 
  
Publication: Bulletin of the World Health Organization; Type: Systematic reviews 
Article ID: BLT.16.189795 
Page 17 of 35 
Box 2. Inclusion and exclusion criteria for selecting studies for the systematic review 
of dietary trans-fatty acid reduction policies 
Participants 
We included studies covering all age groups from all populations, from high-, middle- 
and low-income countries. 
We excluded studies on pregnant women, animals and cells. 
Interventions 
We included primary studies and systematic reviews evaluating the effects of actions 
to promote TFA reduction by government policy or adopted in specific real or 
experimental settings. 
We excluded studies evaluating the effect of a general or specific diet. 
Comparators 
We included studies where actions to promote TFA reduction were evaluated or 
compared. 
We excluded studies with no evaluation or comparison of actions to promote TFA 
reduction. 
Outcomes 
We included primary outcome of interest was change in dietary TFA intake, reported 
as g/day. When TFA intake was reported as percentage of energy from total fat, 
values were converted to g/day. Secondary outcomes included changes in clinical or 
physiological indicators related to noncommunicable diseases and behaviours 
associated with a healthy diet. 
We excluded process evaluations reporting on implementation of interventions or 
policies without any quantitative outcome data; feasibility or acceptability studies 
without an assessment or primary outcomes (intake); studies on individuals as 
opposed to populations; data on cost only; reduction in product content only; body 
mass index studies. 
Study design 
We included primary studies, randomized controlled trials, systematic reviews, 
empirical observational studies, natural experiments,a secondary analysis, before 
and after interventions, and modelling studies. 
We excluded commentary or opinion articles; purely qualitative evaluations with no 
quantitative assessment. 
TFA: trans-fatty acid. 
a
 An empirical study whereby the exposure to the experimental and control groups are determined by 
nature or other factors outside the control of the researchers.  
Notes: Based on the population, intervention, comparison, outcome and study design14 inclusion and 
exclusion criteria. 
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Table 1. Empirical studies categorized according to type of intervention included in the systematic review of dietary trans-
fatty acid reduction policies 
Study Study 
design 











         























Families were recruited between 
May 2004 and April 2005 and 
completed health assessment at 
baseline and 6 months after 
randomization to intervention or 
control groups. Aboriginal health 
counsellors made regular home 
visits to assist families in setting 
their dietary and physical activity 
goals. Energy and nutrient intake 
was measured using a 24-hour 
recall. The Food Processor 
program (ESHA Research, 




consumption of TFAs from 
0.6 to 0.5 g/day (‒0.2 g/day 
versus +0.6 g/day, P = 0.02) 
after 6 months compared 
with non-intervention 
households who increased 
their consumption from 0.7 
to 1.3 g/day.  
There may have 
been bias due to 
self-reporting of 
lifestyle changes and 
the 24-hour dietary 
recall. 
The focus of the 
intervention was not 
TFA but many other 
dietary components 
as well as knowledge 







         











using a low-fat 












and 44 control) 
At weeks 0 and 22, participants 
completed 3-day dietary records 
to assess energy and nutrient 
intake. 
At the intervention site, 
participants were asked to follow 
a low-fat vegan diet and 
participate in weekly group 
meetings that included 
instruction and group support 
(intervention group). At the 
control site, participants received 
no instruction (control group)  
In the intervention group, 
reported intake of TFA, 
decreased significantly 
(P ≤ 0.001) compared with 
the control group. 
TFA intakes in the 
intervention group were: 
2.1 g/day (SD: 0.1) at 
baseline and 1.1 g/day (SD: 
0.1) after 22 weeks. Mean 
difference: ‒1.0 g/day (SD: 
0.2). TFA intake in the 
control group was 2.4 g/day 
(SD: 0.1) at baseline and 
2.5 g/day (SD: 0.2) after 22 
weeks. Mean difference: 
+0.2 g/day (SD: 0.2). Mean 
effect size: ‒1.2 g/day (95% 
CI: ‒1.7 to ‒0.6). 
Nutrition intake was 
self-reported. 
The study was non-
randomized. 
The trial was limited 
to 22 weeks. 
The focus was on 
nutrition education 
about a low-fat 
vegan diet not TFA 
intake 
Poor 
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Food 
reformulation 





To report the 





and limits on 
TFA in food 
sold by retailers 
or food service 
establishments  
Canada Over 33 000 
respondents 
did a dietary 
recall, 




with null or 
invalid recalls, 
children aged 




The TFA programme was 
evaluated between 2004 and 
2008. Dietary intake data for the 
estimations of TFA and 
saturated fatty intake were from 
a 24-hour food recall survey 
performed in 2004 (Canadian 
Community Health Survey, cycle 
2.2). For the 2008 estimation, the 
TFA and saturated fatty acid 
composition values were 
obtained from the national TFA 
monitoring programme 
A previous study showed 
that the estimated average 
intake of TFA in Canada 
was 8.4 g/day in the mid-
1990s. 
This study showed that TFA 
intake in 2004 dropped 
significantly to 4.9 g/day and 
declined further to 3.4 g/day 
in 2008. On average, there 
was a 30% decrease in TFA 

























Three different partially 
hydrogenated vegetable oil 
formulations (containing 20%, 
35% or 45% TFA) were replaced 
with other fats or oils. Effects on 
coronary heart disease risk were 
estimated based on iso-caloric 
replacement of 7.5% of energy 
from partially hydrogenated 
vegetable oil in an individual’s 
diet 
For partially hydrogenated 
vegetable oils with 20% 
TFA, replacement with 
butter would result in a small 
net decrease in coronary 
heart disease risk (2.7%). 
while replacement with palm 
oil or lard would modestly 
decrease risk (by 7.6% and 
6.0% respectively). 
Replacement with soybean, 
canola or high oleic 
sunflower oils would 
produce the largest 
coronary heart disease risk 
reductions (8.8–9.9%). For 
partially hydrogenated 
vegetable oil with 35% TFA, 
risk reductions for 
replacement fats and oils 
ranged from 11.9% to 
16.0%. Largest predicted 
declines in coronary heart 
disease risk were for 
replacement with vegetable 
oils. For partially 
hydrogenated vegetable oil 
with 45% TFA, predicted 
risk reductions were the 
Estimates were 
based on isocaloric 
replacement of 7.5% 
of energy from 
partially 
hydrogenated 
vegetable oil, but 
consumption of 
these oils may be 
higher or lower in 
different populations. 
It is possible that 
saturated fatty acids 
of different chain 
lengths may have 








reductions than the 
analysis of 
prospective cohort 
studies in the same 
paper 
Fair 
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highest, including risk 
reductions of 18.7% and 
19.8% for replacement with 
































Three different partially 
hydrogenated vegetable oil 
formulations (containing 20%, 
35% or 45% TFA) were replaced 
with other fats or oils. Effects on 
coronary heart disease risk were 
estimated based on iso-caloric 
replacement of 7.5% of energy 
from partially hydrogenated 
vegetable oil in an individual’s 
diet 
For partially hydrogenated 
vegetable oil with 20% TFA, 
replacement with butter 
would have little net effect 
on coronary heart disease 
risk (0.5% higher risk), while 
replacement with palm oil or 
lard would modestly 
decrease risk (9.1% and 
7.3%, respectively). 
Replacement with high oleic 
sunflower oil would reduce 
risk by 15.9%, and 
replacement with 
cottonseed, soybean or 
canola oils would produce 
the largest reductions in 
coronary heart disease risk 
(19.0–21.8%). For partially 
hydrogenated vegetable oil 
with 35% TFA, risk 
reductions for replacement 
fats and oils ranged from 
14.4% to 33.4%, with the 
largest predicted declines in 
coronary heart disease risk 
for replacement with 
vegetable oils. For partially 
hydrogenated vegetable oil 
with 45% TFA, predicted 
risk reductions were the 
highest, including risk 
reductions of 39.6% and 
38.6% for replacement with 
soybean and canola oil, 
respectively 
The calculations 
based on cohort 
studies are subject to 
residual confounding 
from other lifestyle 
factors and to 
measurement error 







heart disease risk 
reductions than the 
analysis of 
randomized 




         
Angell et al., 
201224 
Pre‒post test To assess the 
effect of the 









Brief surveys of adult lunchtime 
restaurant customers were 
conducted in 2007 and 2009, 
before and after implementation 
Overall, mean TFA per 
purchase decreased by 
from 2.91 g to 0.51 g 
(change ‒2.4 g; 95% CI: ‒
The fast-food 
restaurants included 
may not have be 
representative of all 
Good 
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7885 in 2009 
of the regulation. Purchase 
receipts were matched to 
available nutritional information. 
Measurements included change 
in mean grams of TFA, saturated 
fat, trans plus saturated fat 
together and TFA per 1000 kcal 
per purchase, overall and by 
type of restaurant 
2.8 to ‒2.0) from 2007 to 
2009. Mean TFA per 1000 
kcal decreased from 3.16 g 
to 0.51 g (change ‒2.7 g per 
1000 kcal (95% CI: ‒3.1 to ‒
2.3) 
New York city 
restaurants. 
Non-chain 
restaurants were not 
included in the 
survey sample 
because they were 






The study design 
was cross-sectional, 
and therefore 





Pre‒post test To analyse the 












over study: 11 
counties; 165 
samples. 






Between 2007 and 2011, a ban 
on TFA in restaurants was 
implemented by the health 
departments of six New York city 
counties and New York. Data on 
annual mortality rates over the 
period 1999‒2013 were 
obtained for all counties of New 
York state from a publicly 
available national database. 
Comparable data was obtained 
for the New York metropolitan 
area. Effective dates of bans for 
each county were obtained from 
the state department of health. 
Panel regression models were 
used to evaluate the effect of the 
bans 
After the ban on TFA in 
restaurants a 4.5% 
reduction in cardiovascular 
disease mortality rates was 
found, or 13 fewer 
cardiovascular disease 
deaths per 100 000 persons 
per year over 2010‒2013. 
The deaths averted were 
valued at about US$ 3.9 
million per 100 000 persons 
annually. 
Deaths attributed to heart 
disease decreased by about 
11 per 100 000 persons, 
and the corresponding 
estimated reduction in 
deaths attributed to strokes 




the impact of a TFA 
ban on mortality 
caused by heart 
disease that may 
operate through a 
variety of channels, 
not only through 
reduced TFA intake 
from food eaten 
away from home 
Changes in the 
amount artificial TFA 
in fast-food-chain 
purchases after bans 
may not have been 
representative of 
other areas of the 
state or of all food 
service 
establishments in the 
counties. 
Medical evidence 
was used to estimate 
mortality was based 
on risk factors such 
Good 
Publication: Bulletin of the World Health Organization; Type: Systematic reviews 
Article ID: BLT.16.189795 




Thus, the USA Food 
and Drug 
Administration’s 
estimate of the 
mortality impact of a 
reduction in TFA 
intake may 
underestimate the 
total impact of TFA 
intake on heart 
disease mortality 





pre‒post test  
To determine 
the effect of TFA 
restrictions in 























there were 8.4 
million adults 
aged 45‒ >  65 




and 3.3 million 




TFA restrictions were 
implemented in in 2007. 
Annual hospital admissions for 
myocardial infarction and stroke 
in all counties were tracked from 
January 2002 to December 
2013, using central government 
national monitoring data.  
Admission rates were calculated 
by year, age, sex and county of 
residence. A difference-in-
differences regression design 
was used to compare admission 
rates in populations with and 
without TFA restrictions. 
Restrictions on TFA content in 
food products in restaurants 
were only implemented in highly 
urban counties. Non-restriction 
counties of similar urbanicity 
were chosen as a comparison 
population. Temporal trends and 
county characteristics were 
accounted for using fixed effects 
by county and year, as well as 
linear time trends by county. 
Results were adjusted for age, 
sex and commuting between 




Three or more years after 
the intervention, myocardial 
infarction and stroke events 
combined (‒6.2%; 95% CI: 
‒9.2 to ‒3.2) were 
significantly lower in in the 
population with TFA 
restrictions, after adjusting 
for temporal trends. This 
was equivalent to 43 events 
averted per 100 000 people. 
There were also significant 
additional decreases in 
myocardial infarction (‒
7.8%; 95% CI: ‒12.7 to ‒
2.8) and a nonsignificant 
decline in stroke (‒3.6%; 
95% CI: ‒7.6 to 0.4) 
compared with the non-
restriction population, after 
adjusting for temporal trends  
The study was 
unable to assess 
population-level 
changes in TFA 
consumption. Race 
and ethnicity was 
poorly reported in the 
state’s data reporting 
system and therefore 
the results were not 
adjusted for it or 
stratified by race and 
ethnicity. Myocardial 
infarction and stroke 
events that did not 
result in hospital 
admission within the 
state were not 
captured. The study 
controlled for linear 
trends over time on 
the county level. 
However, additional 
differences between 
counties could have 
developed over time 
that were not 
accounted for in the 
analysis 
Good 
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Leth et al., 
200631 
Pre‒post test To assess the 
effectiveness of 
Denmark’s ban 
on TFA in 
industrial food 
products 
TFA ban Denmark 253 food 
samples 
before ban; 
148 after ban 
A ban on TFA was introduced in 
2003. 
Food samples were collected 
before (between end of 2002 
and early 2003) and after the 
ban (between November 2004 
and February 2005). TFA 
content was analysed in both 
imported and domestically 
produced food products. 
Categories included chocolate 
and confectionary products, 
sweets, industrial baking 
products (e.g. cookies) and 
French fries 
TFA intake decreased from 
4.5 g/day in 1976 to 1.5 
g/day in 1995. TFAs were 
virtually eliminated from 
margarines and shortenings 
in 2005 after the ban 
There was no clear 
structure to the paper 
or clear introduction 
or method section. 
There was also only 











fatty acids and 
TFA in the diet 
of Costa Rican 
adolescents 
changed during 










Costa Rica 276 
adolescents 
(aged 12–17 
years) in 1996; 
133 in 2006 
TFA interventions were 
implemented from 1996 to 2006. 
Cross-sectional comparisons 
used data from measured food 
records adolescents surveyed in 
1996 and a similar group of 
adolescents surveyed in 2006. 
Values obtained in 1996 and 
2006 were compared with the 
latest WHO guidelines for 
chronic disease prevention 
In 2006, 68% of 
adolescents exceeded the 
upper limit on TFA intake 
(> 1% of total energy), with 
intakes ranging mostly 
around 1% to 2% and 2% to 
3% of total energy. This was 
an improvement from 1996, 
when 100% of teenagers 
reported TFA intakes > 1% 
of total energy, mostly 
around > 4% of total energy. 
TFA intake in 1996 was 
2.1% of total energy (SD: 
0.9) and in 2006 was 1.3% 
of total energy (SD: 0.5). 
Energy-adjusted intake of 
TFA in 1996 was 4.52 g/day 
(SD: 0.74) and in 2006 was 
2.80 g/day (SD: 1.04; 
P = 0.003) 
Demographically 
similar groups were 
used in 2006 
compared with 1996. 
The focus was on 
soybean oil but not 
on products 
generally eaten by 
adolescents, e.g. 
biscuits with cream 
filling or hard 
chocolate coating, 
which contribute the 
largest % of industrial 





Pre‒post test To determine 
whether 
introduction of 
labelling of TFA 






Canada 103 breastmilk 
samples in 
1998; 
87 samples in 
2004‒2006  
TFA labelling was introduced in 
2003. Samples of breastmilk 
(60–100 mL) were collected at 1-
month postpartum during the 
course of a feeding. 
Samples in 1998 were 
compared with samples from 
Mean concentration of total 
TFA in milk collected in 
1998 was 7.1 g/100 g milk 
fatty acids (range: 2.2‒18.7). 
Mean values for milk 
collected and analysed in 
three consecutive 5-month 
TFA intake was 
calculated by the 
authors themselves 
using TFA content in 
human breastmilk. 
Participants in 1998 
were not the same 
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reduction of 
TFAs from 
vegetable oils in 
many foods was 
accompanied by 




2004 to 2006 periods from November 
2004 to January 2006 were 
6.2 g/100 g milk fatty acids 
(range: 3.4–13.7), 
5.3 g/100 g (range: 3.0–
14.5) and 4.6 g/100 g 
(range: 2.2–12.2), 
respectively. 
Estimated mean intake of 
TFA by women were 
4.0 g/day (range: 0.5–12.3) 
in 1998 and 3.4 (range: 1.4–
8.7), 2.7 (range: 1.1–9.3) 
and 2.2 g/day (range: 0.6–
7.7) in three consecutive 5-
month periods from 
November 2004 to January 
2006, respectively 
ones as in 2004‒
2006. 
Baseline data came 
from 1998 not from 
























Mandatory labelling came into 
force in 2005 with 
voluntary limits agreed with the 
food industry in 2007. 
Samples were collected from 
breastfeeding mothers in 10 
major cities across Canada. TFA 
content of human milk was 
estimated using a previously 
established linear correlation 
between the percentage of TFAs 
in the diet and human milk fat, 
and assuming that 30% of the 
energy of a lactating mother's 
diet is derived from fat 
Mean TFA content of 
breastmilk were 2.7% (SD: 
0.9; range: 1.4‒7.2%), 2.2% 
(SD: 0.7%; range: 1.0‒
6.8%) and 1.9% (SD: 0.5; 
range: 0.9‒3.4%) of total 
milk fat for samples 
collected in 2009 (n = 152), 
2010 (n = 309) and 2011 
(n = 177), respectively. 
These values were 
considerably lower than the 
value of 7.2% (SD: 3.0; 
range: 0.1‒17.2%) (n = 198) 
found previously for 
Canadian human milk in 
1992. 
Estimated TFA intake of 
Canadian breastfeeding 
mothers was 0.9% 
(2 g/day), 0.5% (1.1 g/day), 
and 0.3% (0.7 g/day) of total 
energy in 2009, 2010 and 
2011, respectively 
Breastmilk values 
were estimated as % 
of total energy and 
converted to g/day. 
The TFA intake of 
mothers were lower 
than the WHO's 
maximum 
recommended TFA 
intake of 1% of total 
energy for a healthy 
diet 
Fair 












2000 and 292 
in 2009 
TFA content of foods was to be 
declared on the nutrition label 
after 2003. Some community 
and state departments required 
Levels of TFAs were 
detectable in all samples. 
Levels of vaccenic acid 
decreased by 56% from 
The study was only 
reported as a 
research letter. 
The study measured 
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content of foods 
and voluntary 
limits on TFA in 
restaurants 
were introduced  
restaurants to limit TFA content 
in food products. Data were from 
the National Health and Nutrition 
Examination Surveys in 2000 
and 2009. 
Participants were selected if they 
had morning fasting blood 
samples. 
Four TFAs (elaidic acid, vaccenic 
acid, linoelaidic acid and 
palmitelaidic acid) were 
measured in plasma 
43.7 µmol/L in 2000 to 19.4 
µmol/L in 2009 (difference 
of 24.3 µmol/L; 95% CI: 
19.6 to 29.0). Similar 
changes were seen in 
elaidic acid, palmitelaidic 
acid and linoelaidic acid. 
Weighted geometric mean 
of the difference for the sum 
of all four TFAs was 54.1 
µmol/L (95% CI: 43.4 to 
64.7 µmol/L) or 58% lower 
in samples from 2009 (39.0 
µmol/L) than from 2000 
(93.1 µmol/L) 
percentage 
decreases of TFAs in 
blood samples rather 
than g/day 
CI: confidence interval; DALYs: disability-adjusted life years; EU: European Union; N/A: not applicable; SD: standard deviation; TFA: trans-fatty acid; US$: United 
States dollars; WHO: World Health Organization. 
a
 We used the National Heart, Lung and Blood Institute quality assessment tools to assess the quality of empirical studies.17 
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Table 2. Modelling studies included in the systematic review of dietary trans-fatty acid reduction policies 






Methods Outcomes Comments Qualitya 
Allen et al., 
201532 
To determine the 












levels in England 






TFAs; (iii) bans 








For policies aimed at reducing 
consumption, health benefits and 
cost outcomes were calculated 
for 2015‒2020 in England only. 
Government national data and 
health economic data from other 
published studies were used for 
the model. Adults were stratified 
by fifths of socioeconomic 
circumstances 
A total ban on TFAs in processed 
foods: might prevent or postpone 
about 7200 (2.6%) of the 273 000 
total deaths from coronary heart 
disease from 2015‒2020 and 
reduce socioeconomic inequality 
in mortality from coronary heart 
disease by about 3000 of 20 400 
deaths (14.7%). Policies to 
improve labelling: could save 3500 
(1.3%) of 273 000 total deaths 
from coronary heart disease and 
reduce inequalities by 1500 (7.4%) 
of 20 400 deaths, thus making 
them at best half as effective as a 
ban. Policies to simply remove 
TFAs from restaurants or fast-
foods: could save between 1800 
(0.7%) and 2600 (1.0%) of the 
273 000 total deaths from 
coronary heart disease and 
reduce inequalities by 600 (2.9%) 
to 1200 (5.9%) of the 20 400 
deaths. A total ban would have the 
greatest net cost savings of about 
£ 265 million, excluding 
reformulation costs, or £ 64 million 
if substantial reformulation costs 
are incurred  
The health outcomes analysis 
assumed continuing declines 
in incidence of and mortality 
from coronary heart disease. 
The study used an area-based 
measure of socioeconomic 
status. Within an area there 
will be individuals of higher 
and lower socioeconomic 
status. Therefore, the study 
could not make firm 
conclusions about individuals. 
As the effect of TFAs operated 
on a percentage basis (food 
energy from TFAs divided by 
total food energy), differences 
between surveys could only 
affect the results if 
consumption were 
substantially misreported in 





To assess the 
added value of 
EU-level action 























EU EU population  
(numbers not 
stated)  
A computer-simulated model 
was developed, using effect 
sizes from different studies, 
complemented with results from 
a survey of EU Member States. 
The model considered three 
types of cost: (i) health care 
costs, (ii) non-health care costs 
and (iii) costs of policy-
associated measures 
The model estimated that 
imposing an EU-level legal limit 
would avoid the loss of 3.73 of 
1073 million DALYs due to 
coronary artery disease over the 
course of a person’s lifetime (85 
years), and making voluntary 
agreements would avoid 2.19 of 
1076 million DALYs. Imposing 
EU-level legal limits: would save 
an estimated € 51 billion of 
€ 10 723 635 million in total costs 
when compared with the 
Major sources of potential 
errors were the estimated 
current TFA intake; the wide 
variability observed for many 
variables between EU 
countries; and the lack of data 
in some instances, e.g. lack of 
data on number of coronary 
artery disease events per year 
(coronary artery disease-
related hospital discharges 
were used instead). 
The results should be 
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industrially 
produced TFA 
content in food; 





reference situation and voluntary 
agreements would save € 23 
billion (of € 10 752 032 million). 
Implementing mandatory TFA 
labelling: could also avoid the loss 
of 0.98 of 1076 million DALYs, but 
this option incurred greater costs 
(€ +95 billion) than it saved 
compared with the reference 
option 
interpreted as a comparison 
between different policy 
options rather than 
considering absolute costs, 
DALYs or deaths per option 






of consuming a 
diet consisting of 
products that 
comply with the 
criteria for a 
healthier choice 
logo 




The healthier choices logo for 
food packages was implemented 
in 2006. National food 
consumption and food 
composition data were used to 
estimate the nutrient intake of the 
Dutch adult population before 
and after replacing foods that did 
not comply with the choices 
criteria. Four different scenarios 
were modelled: 
(i) reference; 
(ii) minimum, if 24% of the 
population replaced their food 
products which complied with the 
label criteria; (iii) medium, if 48% 
replaced their food products 
which complied with the label 
criteria; 
(iv) maximum, if 100% replaced 
their food products which 
complied with the label criteria. 
The difference in cholesterol 
levels in the Dutch population 
was assessed before and after 
replacement by means of 
equations from meta-analyses 
that calculated how blood lipids 
change when diet composition 
changes 
Replacing non-complying 
products with products that 
complied with the label’s criteria: 
median intakes of TFA (as a % of 
total energy intake) would fall from 
the reference value of 0.95% 
(2.1 g/day) to 0.80% (1.8 g/day), 
0.70% (1.6 g/day) and 0.57% 
(1.3 g/day) in the minimum, 
medium and maximum scenarios, 
respectively 
The study was based on 
theoretical food replacements 
not people’s actual practices. 
The study assumed that 
people would eat the same 
amounts of replacement foods 
as their traditional choice, 
whereas people may eat high 
amounts of products they 
perceive to be healthier. 
The minimum scenario was 
based on a single study that 
may not be representative of 
the general population. The 
available national 
representative food 
consumption data used were 




et al., 201335 






Food labelling Netherlands 750 Young Dutch 
adults (aged 19–
30 years)  
Data from the 2003 Dutch food 
consumption survey in young 
adults and the Dutch food 
composition tables were 
combined into a Monte-Carlo risk 
assessment model. Three 
An estimated reduction of ‒62% 
for TFA intake was found when 
foods complied with the choices 
labelling programme compared 
with the actual scenario. 
TFA intakes in the different 
Replacements chosen may be 
susceptible to some 
subjectivity and bias. 
Product acceptability was not 
taken into consideration. The 
same replacement food was 
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effect on nutrient 
intakes 
scenarios were calculated: 
(i) actual intakes; (ii) intakes 
when all foods that did not 
comply with the healthy choices 
criteria were replaced by similar 
foods that did comply; (iii) intakes 
when food replacements were 
adjusted for the difference in 
energy density between the 
original and replacement food. 
Another two scenarios were 
calculated where snacks were 
not replaced or partially replaced 
scenarios were 2.2 g/day for the 
actual scenario; 0.8 g/day for the 
choices labelling programme and 
1.0 g/day for the choices labelling 
programme, adjusted for energy. 
TFA intakes were 1.3 g/day and 
1.4 g/day, when snacks were 
partially replaced or not replaced, 
respectively 
used for a large number of 
snacks. Snacks are usually 
eaten for indulgence; therefore 
it is unrealistic to assume that 
consumers will replace all 
snacks with the same healthier 
alternative 
De Menezes 
et al., 201336 










and added sugar 
in the typical 
Brazilian diet 
Food labelling Brazil 1720 food 
products in the 
Brazilian diet 
Data on industrialized and 
packaged products available in 
the market in São Paulo state 
were collected in 2011. The 
sources of nutritional information 
were product labels or websites. 
To evaluate the impact of the 
consumption of products aligned 
with the choices criteria, 
ingestion of key compounds was 
estimated based on theoretical 
menus. Typical menus 
consumed by the Brazilian 
population were compared with 
the choices menu (and with the 
choices menu with energy 
adjustment). The estimated 
menus were based on data from 
a Brazilian household budget 
survey carried out between 2008 
and 2009 
Replacement of typical products 
by those meeting the choices 
criteria was estimated to cause a 
decrease in the intake of TFAs of 
92%. Estimated TFA intakes 
were: 0.8 g/day (SD: 1.0) for 
typical menus; 0.1 g/day (SD: 0.2) 
for choices menus; and 0.2 g/day 
(SD: 0.3) for energy-adjusted 
choices menus, i.e. the same as 
choices menu but adjusted for 
energy of typical menu 
The study compared the 
typical menu with the choices 
criteria to see how the intake 
of dietary components might 
change. There was no specific 




To estimate the 
impact of recent 
reformulations of 
food groups in 
the Netherlands 
on median intake 





Netherlands 750 young adults 
(aged 19‒30 
years): 352 men, 
398 women 
Intakes of TFA were estimated 
before reformulation (started in 
2003), using national food 
composition data of 2001 as a 
reference and including most 
recent TFA composition of foods. 
Food composition of other foods 
and food consumption was 
assumed to be unchanged 
Average TFA intake decreased 
significantly from 2.3 g/day (95% 
CI: 2.2 to 2.5) to 1.9 g/day (95% 
CI: 1.8 to 2.0) in the reformulation 
scenario. Pastry, cakes and 
biscuits, and snacks contributed 
most to the decrease of TFA than 
potato, bread, fats and 
margarines. Median TFA intakes 
were 2.3 g/day (95% CI: 2.2 to 
2.5) in the reference scenario and 
1.9 g/day (95% CI: 1.8 to 2.0) in 
Composition data provided by 
members of the Dutch task 
force for the improvement of 
fatty acid composition was 
purchasing data not actual 
intake data. Therefore it was 
not always possible to link this 
information with food 
consumption data 
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the reformulation scenario. 
Estimated reduction in TFA intake 















Denmark Danish population 
(number not 
stated) 
A policy restricting the content of 
artificial TFA in certain food 
ingredients was implemented in 
2004. Annual mortality rates in 
OECD and Development 
countries from 1990 to 2012 
were used to estimate the effect 
of Denmark's food policy on 
cardiovascular disease mortality 
rates. A synthetic control group 
was composed of a weighted 
average of other OECD 
countries that did not implement 
the policy. Analyses were 
conducted in 2015 
In the period before the policy 
(1990‒2003), the mean annual 
number of deaths per 100 000 
people in Denmark were 441.5 
and in the synthetic control group 
were 442.7. In the 3 years after the 
policy was implemented (2004‒
2006), mortality attributable to 
cardiovascular disease decreased 
on average by 14.2 deaths per 
100 000 people per year in 
Denmark relative to the synthetic 
control group. The policy reduced 
male and female cardiovascular 
disease deaths by 24.4 per 
100 000 and 14.3 per 100 000 per 
year over the 2004–2006 period, 
respectively. For coronary heart 
disease, the estimated reduction 
over the 2004–2006 period was 
26.5 deaths per 100 000 people 
per year 
The study investigated what 
would have happened if 
mandatory reformulation had 
not been applied in Denmark. 
The paper focuses on 2004–
2006 before the anti-smoking 
law was implemented.  
Good 
Barton et al., 
201139 
To estimate the 
potential cost‒












England and Wales Entire population 
aged 40‒79 years 
(about 50 million) 
A spreadsheet model was used, 
with a range of possible 
interventions to quantify the 
reduction in cardiovascular 
disease over a decade, 
assuming the benefits applied 
consistently for men and women 
across age and risk groups 
Legislation to reduce intake of 
industrial TFA by approximately 
0.5% (from 0.8% to 0.3%) of total 
energy content could prevent 
approximately 2700 deaths 
annually and thus gain 570 000 life 
years and generate savings to the 
national health service worth at 
least £ 230 million a year 
The study made no attempt to 
consider recurrent events or 
subsequent deaths. The 
estimates of deaths avoided, 
life years gained and cost 
savings were thus likely to be 
underestimates, making the 
analysis conservative. The 
study only modelled a 10-year 
timeframe; reduction in 
cardiovascular disease would 
clearly be greater over a 
lifetime. The analysis was 
pragmatically limited to people 
aged between 40 and 79 
years at the time of the 
intervention. This initial 
modelling lacked a full 
probabilistic sensitivity analysis 
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O’Flaherty et 
al., 201240 




could be reduced 





(i) Target of 
0.5% decrease 
in the fraction of 
total energy 
derived from 
TFA by 2015; 
(ii) legislative 
ban 
United Kingdom Adults aged 25‒84 
years (number not 
stated) 
Potential reductions in 
cardiovascular disease mortality 
in the United Kingdom between 
2006 (baseline) and 2015 were 
estimated by synthesizing data 
on population, diet and mortality. 
The effect of specific dietary 
changes on cardiovascular 
disease mortality was obtained 
from recent meta-analyses. The 
potential reduction in 
cardiovascular disease deaths 
was then estimated for two 
dietary policy scenarios: 
(i) conservative scenario, with 
modest improvements 
(assuming recent trends would 
continue until 2015); 
(ii) aggressive scenario. with 
more substantial but feasible 
reductions (already seen in 
several countries) in saturated 
fats, industrial TFAs and salt 
consumption, plus increased fruit 
and vegetable intake. A 
probabilistic sensitivity analysis 
was conducted 
In the conservative scenario: 
reducing the TFA intake by 0.5% 
in total energy, approximately 
3500 of the 12 500 total 
cardiovascular disease deaths 
would be prevented. In the 
aggressive scenario: effectively 
eliminating the consumption of 
TFA (to reach 0% of total energy) 
could result in approximately 4700 
of the 29 900 fewer cardiovascular 
disease deaths (range: 2500–
8800) per year 
The study did not explicitly 
model lag times. 
The study assumed that the 
effects of food policies on 
dietary intake in the United 
Kingdom would be 
quantitatively similar to those 
in other countries, without 
explicitly considering political, 
commercial, cultural and 
socioeconomic differences or 
whether countries’ baseline 
dietary values were high or 
low. 
The study assumed 
commercial vested interests 





To quantify the 
potential health 
effects and costs 





intake of TFA  
(i) Elimination of 
industrial TFA; 
(ii) elimination of 
both industrial 
and natural TFA 
England and Wales England and 
Wales population 
stratified by age, 
sex and 
socioeconomic 
status (number not 
stated) 
The study extended a previously 
validated model to estimate the 
potential effects on health and 
economic outcomes of 
mandatory reformulation or a 
complete ban on dietary TFA in 
manufactured products in 
England and Wales from 2011 to 
2020. 
Two policy scenarios were 
modelled: (i) elimination of 
industrial TFA consumption from 
0.8% to 0.4% daily energy; 
(ii) elimination of all TFA 
consumption from 0.8% to 0% 
Elimination of all TFA resulted in 
the largest gains in mortality and 
life years, with slightly larger gains 
when modelling unequal baseline 
TFA by socioeconomic status. 
Scenario 1 (elimination of 
industrial TFA only) 
Annual deaths prevented: 1700. 
Annual life-years gained: 15 000. 
Annual hospital admissions 
averted: 4400. Hospital 
admissions averted over 10 years: 
38 000 
Scenario 2 (elimination of all TFA) 
Annual deaths prevented: 3300. 
Annual life-years gained: 29 000. 
Annual hospital admissions 
averted: 8400. Hospital 
admissions averted over 10 years: 
The model assumed 
immediate health benefits. 
However, rapid improvements 
might reasonably be expected. 
The study assumed equal 
mortality gains from 
elimination of natural and 
industrial TFAs 
Good 
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To estimate the 
impact of policies 












Argentina Adults aged 34+ 
years (number not 
stated) 
Baseline intake of TFA before 
2004 was estimated to be 1.5% 
of total energy intake. A policy 
model was built including 
baseline intake of TFA, the oils 
and fats used to replace artificial 
TFAs, the clinical effect of 
reducing artificial TFAs and the 
costs and DALYs saved due to 
the coronary heart disease 
events averted. 
To calculate the percentage 
reduction of risk, coronary heart 
disease risks were calculated on 
a population-based sample 
before and after implementation 
of the intervention. 
The effect of the policies was 
modelled in three ways, based 
on (i) projected changes in 
plasma lipid profiles; (ii) projected 
changes in lipid and 
inflammatory biomarkers; and 
(iii) the results of prospective 
cohort studies. 
The current economic value of 
DALYs and associated health-
care costs of coronary heart 
disease averted were also 
estimated 
Baseline number of deaths were: 
24 875 for coronary heart disease 
and 17 942 for acute myocardial 
infarction. Baseline costs were: 
US$ 6416 per acute coronary 
syndrome, US$ 5765 per acute 
myocardial infarction, 
US$ 1199 per follow-up and 
treatment, and US$: 129 001 for 
programmatic costs. 
The proportion of CHD events 
averted by the modelled TFA 
reduction policy in 2014 ranged 
from 1.3% (scenario 1) to 6.4% 
(scenario 3) of the total. The 
estimated reductions in coronary 
heart disease were sensitive to the 
assumed baseline TFA intake in 
2004. 
Based on projected changes in 
plasma lipid profiles: an estimated 
301 coronary heart disease 
deaths, 572 acute myocardial 
infarctions, 1066 acute coronary 
heart disease events and 5237 
DALYs would be annually averted 
after 2014. This is calculated 
compared with the expected 
events if the policy had not been 
implemented. In addition, more 
than US$ 17 million would be 
saved annually due to acute 
coronary heart disease events 
averted and lower costs of chronic 
treatment and follow-up. 
Based on projected changes in 
lipid and inflammatory biomarkers: 
using the baseline estimate of 
1.5% energy intake from TFA, a 
total of 3109 acute coronary heart 
disease events, 15 271 DALYs 
and more than US$ 50 million in 
costs would be annually averted 
after 2014. 
Based on the results of 
The cardiovascular risk 
calculator used was based on 
equations developed a couple 
decades before when the 
coronary heart disease 
incidence was higher in 
Argentina. 
The study used global 
percentage estimates to adjust 
for under-reporting of mortality 
from coronary heart disease. 
The study only looked at cost 
from a health system 
perspective and not at the cost 
for the industry to reformulate. 
The study did not have precise 
data on baseline TFA and the 
level of this would influence 
the results 
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prospective cohort studies  
(baseline): an estimated 1517 
coronary heart disease deaths, 
2884 acute myocardial infarctions, 
5373 acute coronary heart 
disease events and 26 394 DALYs 
would be averted, resulting in 
estimated savings of $US 87 
million 
CI: confidence interval; DALYs: disability-adjusted life years; EU: European Union; OECD: Organisation for Economic Co-operation; £: Pounds sterling; SD: 
standard deviation; TFA: trans-fatty acid; US$: United States dollars; WHO: World Health Organization. 
a
 We used adapted version of a published quality assessment tool by Fattore et al..18 
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Fig. 1. Interventions classified on the upstream‒downstream continuum in the 




Legislation or mandatory 
reformulation of food 
products 
Taxation and subsidies 
Voluntary reformulation of 
food products  
Food labelling 
Mass media campaigns 
Community dietary 
counselling 
Worksite dietary counselling 

















Note: Based on the McLaren continuum of interventions.8 
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Notes: Based on the preferred reporting items for systematic reviews and meta-analyses guidelines.14 
1785 records identified through 
database search 
22 Additional records identified 
through other sources 
1084 records screened after duplicates removed 
1016 records excluded 
47 full-text articles excluded  
‒ 23 had no evaluation of TFA 
interventions (descriptive)  
‒ 11 had no focus on TFAs or TFA 
interventions  
‒ 7 had focus on other outcomes  
‒ 2 studied the effect of TFA 
reduction rather than effect of a policy 
‒ 3 were opinion article or conference 
abstract  
‒ 1 was a systematic review; studies 
were included individually if they met 
the criteria 
23 studies included in 
qualitative synthesis 
70 full-text articles assessed 
for eligibility 
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Fig. 3. Effectiveness of interventions to reduce trans-fatty acid intake in the 
systematic review of dietary reduction policies 
 
 
TFA: trans-fatty acid. 
Notes: Plot of the reported reductions in TFA consumption (g/day) of the 12 empirical studies included in this 
systematic review, by type of intervention. An unweighted median regression model was fitted to the data and 
is depicted by the grey line on the plot. We used the National Heart, Lung and Blood Institute quality 
assessment tools to assess the quality of empirical studies.17 
 
